Source:http://linkedlifedata.com/resource/pubmed/id/14550029
| Subject | Predicate | Object | Context |
|---|---|---|---|
| pubmed-article:14550029 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:14550029 | lifeskim:mentions | umls-concept:C0005574 | lld:lifeskim |
| pubmed-article:14550029 | lifeskim:mentions | umls-concept:C1555307 | lld:lifeskim |
| pubmed-article:14550029 | pubmed:issue | 3-4 | lld:pubmed |
| pubmed-article:14550029 | pubmed:dateCreated | 2003-10-10 | lld:pubmed |
| pubmed-article:14550029 | pubmed:abstractText | Genetic engineering has produced pharmaceuticals, disease-resistant plants, cloned animals and research and industrial products. While the comparably mature field of medical biotechnology now reveals its true potential, marine biotechnology is still in the realm of the future. As we explore the earth for new sources of natural chemicals, we now search the waters. Myriad organisms, most unknown to us, live there. Many produce compounds that can be commercialized, or the organisms themselves may be commercialized, through genetic engineering methods. For decades, scientists studied the ocean depths searching for unique molecules and organisms. But not until the early 1980s was there a synthesis uniting marine natural products, ecology, aquaculture and bioremediation research under the heading of marine biotechnology. As harvesting enough products from marine sources to produce sufficient amounts, even for study, is nearly impossible, we need to use genomics techniques to identify biologically active compounds. As we damage our oceanic ecosystems through pollution, overfishing and destructive fishing methods, opportunities to learn more about marine organisms and their commercial potential may be limited. Although governments and intergovernmental agencies are committed to funding and expanding oceanic research, more funding is needed to discover and study the ocean's vast, unplumbed resources. | lld:pubmed |
| pubmed-article:14550029 | pubmed:language | eng | lld:pubmed |
| pubmed-article:14550029 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14550029 | pubmed:status | PubMed-not-MEDLINE | lld:pubmed |
| pubmed-article:14550029 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:14550029 | pubmed:issn | 0734-9750 | lld:pubmed |
| pubmed-article:14550029 | pubmed:author | pubmed-author:ColwellRita... | lld:pubmed |
| pubmed-article:14550029 | pubmed:issnType | lld:pubmed | |
| pubmed-article:14550029 | pubmed:volume | 20 | lld:pubmed |
| pubmed-article:14550029 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:14550029 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:14550029 | pubmed:pagination | 215-28 | lld:pubmed |
| pubmed-article:14550029 | pubmed:dateRevised | 2006-7-7 | lld:pubmed |
| pubmed-article:14550029 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:14550029 | pubmed:articleTitle | Fulfilling the promise of biotechnology. | lld:pubmed |
| pubmed-article:14550029 | pubmed:affiliation | US National Science Foundation, 4201 Wilson Boulevard, Suite 1205, Arlington, VA 22230, USA. rcolwell@nsf.gov | lld:pubmed |
| pubmed-article:14550029 | pubmed:publicationType | Journal Article | lld:pubmed |